Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1996 3
1997 3
1998 5
1999 2
2000 1
2003 1
2005 1
2006 1
2008 2
2009 2
2010 2
2012 1
2013 2
2014 2
2015 2
2016 2
2017 2
2018 3
2019 3
2020 5
2021 2
2022 3
2023 2
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
van Linschoten RCA, Jansen FM, Pauwels RWM, Smits LJT, Atsma F, Kievit W, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Römkens TEH, Lutgens MWMD, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel MGVM, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan ACITL, van der Woude CJ, Hoentjen F; LADI study group, the Dutch Initiative on Crohn, Colitis (ICC). van Linschoten RCA, et al. Among authors: wolfhagen fhj. Dig Dis Sci. 2024 Jun;69(6):2165-2174. doi: 10.1007/s10620-024-08410-z. Epub 2024 Apr 9. Dig Dis Sci. 2024. PMID: 38594435 Free PMC article. Clinical Trial.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
van Linschoten RCA, Jansen FM, Pauwels RWM, Smits LJT, Atsma F, Kievit W, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Römkens TEH, Lutgens MWMD, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel MGVM, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan ACITL, van der Woude CJ, Hoentjen F; LADI study group and the Dutch Initiative on Crohn and Colitis. van Linschoten RCA, et al. Among authors: wolfhagen fhj. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):343-355. doi: 10.1016/S2468-1253(22)00434-4. Epub 2023 Jan 31. Lancet Gastroenterol Hepatol. 2023. PMID: 36736339 Clinical Trial.
Standardised training for endoscopic mucosal resection of large non-pedunculated colorectal polyps to reduce recurrence (*STAR-LNPCP study): a multicentre cluster randomised trial.
Meulen LWT, Bogie RMM, Siersema PD, Winkens B, Vlug MS, Wolfhagen FHJ, Baven-Pronk M, van der Voorn M, Schwartz MP, Vogelaar L, de Vos Tot Nederveen Cappel WH, Seerden TCJ, Hazen WL, Schrauwen RWM, Alvarez Herrero L, Schreuder RM, van Nunen AB, Stoop E, de Bruin GJ, Bos P, Marsman WA, Kuiper E, de Bièvre M, Alderlieste YA, Roomer R, Groen J, Bargeman M, van Leerdam ME, Roberts-Bos L, Boersma F, Thurnau K, de Vries RS, Ramaker JM, Vleggaar FP, de Ridder RJ, Pellisé M, Bourke MJ, Masclee AAM, Moons LMG. Meulen LWT, et al. Among authors: wolfhagen fhj. Gut. 2024 Apr 5;73(5):741-750. doi: 10.1136/gutjnl-2023-330020. Gut. 2024. PMID: 38216328 Clinical Trial.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
Jansen FM, van Linschoten RCA, Kievit W, Smits LJT, Pauwels RWM, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Römkens TEH, Lutgens MWMD, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel MGVM, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan ACITL, Hoentjen F, van der Woude CJ; LADI study group. Jansen FM, et al. Among authors: wolfhagen fhj. J Crohns Colitis. 2023 Nov 24;17(11):1771-1780. doi: 10.1093/ecco-jcc/jjad101. J Crohns Colitis. 2023. PMID: 37310877 Free PMC article. Clinical Trial.
Effect of optical diagnosis training on recognition and treatment of submucosal invasive colorectal cancer in community hospitals: a prospective multicenter intervention study.
Meulen LWT, Haasnoot KJC, Vlug MS, Wolfhagen FHJ, Baven-Pronk MAMC, van der Voorn MPJA, Schwartz MP, Vogelaar L, de Vos Tot Nederveen Cappel WH, Seerden TCJ, Hazen WL, Schrauwen RWM, Alvarez-Herrero L, Schreuder RM, van Nunen AB, Stoop E, de Bruin GJ, Bos P, Marsman WA, Kuiper E, de Bièvre M, Alderlieste YA, Roomer R, Groen J, Bigirwamungu-Bargeman M, Siersema PD, Elias SG, Masclee AAM, Moons LMG; OPTICAL-STAR study team and the Dutch T1 CRC Working Group. Meulen LWT, et al. Among authors: wolfhagen fhj. Endoscopy. 2024 Oct;56(10):770-779. doi: 10.1055/a-2313-4996. Epub 2024 Apr 24. Endoscopy. 2024. PMID: 38657659 Free PMC article.
Periprocedural adverse events after endoscopic resection of T1 colorectal carcinomas.
van de Ven SEM, Backes Y, Hilbink M, Seerden TCJ, Kessels K, de Vos Tot Nederveen Cappel WH, Groen JN, Wolfhagen FHJ, Geesing JMJ, Borg FT, van Bergeijk J, Spanier BWM, Mundt MW, Pullens HJM, Boonstra JJ, Opsteeg B, van Lent AUG, Schrauwen RWM, Laclé MM, Moons LMG, Terhaar Sive Droste JS; Dutch T1 CRC Working Group. van de Ven SEM, et al. Among authors: wolfhagen fhj. Gastrointest Endosc. 2020 Jan;91(1):142-152.e3. doi: 10.1016/j.gie.2019.08.046. Epub 2019 Sep 13. Gastrointest Endosc. 2020. PMID: 31525362
Prevention and treatment of osteoporosis in primary biliary cirrhosis.
Vleggaar FP, van Buuren HR, Wolfhagen FH, Schalm SW, Pols HA. Vleggaar FP, et al. Among authors: wolfhagen fh. Eur J Gastroenterol Hepatol. 1999 Jun;11(6):617-21. doi: 10.1097/00042737-199906000-00006. Eur J Gastroenterol Hepatol. 1999. PMID: 10418932 Review.
Management of osteoporosis in primary biliary cirrhosis.
Wolfhagen FH, van Buuren HR, Vleggaar FP, Schalm SW. Wolfhagen FH, et al. Baillieres Best Pract Res Clin Gastroenterol. 2000 Aug;14(4):629-41. doi: 10.1053/bega.2000.0108. Baillieres Best Pract Res Clin Gastroenterol. 2000. PMID: 10976019 Review.
56 results